Matches in Nanopublications for { ?s ?p "[Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP774894.RAs8gu3ZVXSoUm3Dz3NWgfJ50xNuqeeBQqLgIlMlw3nuI130_assertion description "[Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP774894.RAs8gu3ZVXSoUm3Dz3NWgfJ50xNuqeeBQqLgIlMlw3nuI130_provenance.
- NP977906.RADVoAO9LIG5ycdK3p6H5OeRcxY9H7Rv0tLHo5dEk5HRQ130_assertion description "[Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977906.RADVoAO9LIG5ycdK3p6H5OeRcxY9H7Rv0tLHo5dEk5HRQ130_provenance.
- NP189298.RA9aV9zF2T_XRy6nfxoSxxO1Ibj1V8LTfWsmG_yrN9b7k130_assertion description "[Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP189298.RA9aV9zF2T_XRy6nfxoSxxO1Ibj1V8LTfWsmG_yrN9b7k130_provenance.
- assertion description "[Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP868485.RAbARkNl9IasWqF3lmgZU4nptrhN6HbnxMa_tAZR4MnRQ130_assertion description "[Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868485.RAbARkNl9IasWqF3lmgZU4nptrhN6HbnxMa_tAZR4MnRQ130_provenance.
- NP133437.RAqlkoS9LPHYSBCRqqKZZGJ0Wh-2oz0FFmz47swFtA8H8130_assertion description "[Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133437.RAqlkoS9LPHYSBCRqqKZZGJ0Wh-2oz0FFmz47swFtA8H8130_provenance.
- NP868488.RAqc39K7D7exJUBCXmPYpR5oLjI-TGNED4-T_vjabZggk130_assertion description "[Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868488.RAqc39K7D7exJUBCXmPYpR5oLjI-TGNED4-T_vjabZggk130_provenance.
- assertion description "[Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.